Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−38.41 M USD
52.47 M USD
11.76 M
About Centogene N.V.
Sector
CEO
Kim Stratton
Website
Headquarters
Rostock
Founded
2018
ISIN
NL0014040206
FIGI
BBG00QKF19S5
Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It operates through the following segments: Pharmaceutical, Diagnostics, and Corporate. The Pharmaceutical segment provides solutions to pharmaceutical partners, including target discovery, early patient recruitment and identification, epidemiological insights, and biomarker discovery. The Diagnostics segment offers genetic sequencing and diagnostics services to clients, who are typically physicians, laboratories, or hospitals, either directly or through distributors. The Other segment covers COVID-19 testing services to clients. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CNTGF is 0.1200 USD — it has decreased by −14.29% in the past 24 hours. Watch Centogene N.V. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Centogene N.V. stocks are traded under the ticker CNTGF.
CNTGF stock has fallen by −7.69% compared to the previous week, the month change is a −4.76% fall, over the last year Centogene N.V. has showed a −89.74% decrease.
CNTGF reached its all-time high on Mar 19, 2020 with the price of 28.7109 USD, and its all-time low was 0.0550 USD and was reached on Sep 11, 2024. View more price dynamics on CNTGF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CNTGF stock is 16.67% volatile and has beta coefficient of −0.20. Track Centogene N.V. stock price on the chart and check out the list of the most volatile stocks — is Centogene N.V. there?
Today Centogene N.V. has the market capitalization of 3.48 M, it has increased by 14.04% over the last week.
Yes, you can track Centogene N.V. financials in yearly and quarterly reports right on TradingView.
Centogene N.V. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
No, CNTGF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 493.00 employees. See our rating of the largest employees — is Centogene N.V. on this list?
Like other stocks, CNTGF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Centogene N.V. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Centogene N.V. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Centogene N.V. stock shows the sell signal. See more of Centogene N.V. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.